Sentynl Therapeutics, Inc.
Grant Castor leads global commercial strategy, finance, and operations for the portfolio of therapeutics in rare and ultra-rare diseases at Sentynl Therapeutics, Inc. Prior to this, Grant held various roles in commercial operations and marketing at Amedra Pharmaceuticals LLC, Hemaclear, OHK Medical Devices, Allied Orthopedic Associates - Zimmer Spine, and Prescient Medical, Inc. Grant holds a B. Sc. in International Business from Johnson & Wales University.
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.